ELIXIR PHARMACEUTICALS, INC.

Profile

Company Names

ELIXIR PHARMACEUTICALS, INC.

Addresses

12 EMILY STREET, CAMBRIDGE, MA 02139

Phone Numbers

617-995-7000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$11,994,995.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-05-15 
$11,994,995.00 
$25,000,000.00 
$13,005,005.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VERNON 
 
CASSIN 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.
PETER 
S. 
DISTEFANO 
EXECUTIVE OFFICER
ELIXIR PHARMACEUTICALS, INC.
ANSBERT 
 
GADICKE 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  CERIMON PHARMACEUTICALS, INC.   |  MPM BIOVENTURES V, L.P.   |  VERASTEM, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  MITOKYNE, INC.   |  CLINICAL INK, INC.   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  ITEOS THERAPEUTICS, INC.   |  ONCOLOGY IMPACT FUND 2, L.P.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEXTPOINT THERAPEUTICS, INC.   |  MPM BIOVENTURES 2022, L.P.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
KENNETH 
 
GREENBERG 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  SONOTHERA, INC.
VAUGHN 
M. 
KAILIAN 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  XANODYNE PHARMACEUTICALS INC   |  MPM BIOVENTURES V, L.P.   |  RHYTHM HOLDING COMPANY, LLC
ROBERT 
 
KRIEBEL 
EXECUTIVE OFFICER
ELIXIR PHARMACEUTICALS, INC.
DION 
 
MADSEN 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  HALOSOURCE INC   |  SURFACE LOGIX INC   |  ON-Q-ITY, INC.   |  ZYMEWORKS INC.   |  MILESTONE PHARMACEUTICALS INC.
PAUL 
M. 
MARTHA 
EXECUTIVE OFFICER, DIRECTOR
ELIXIR PHARMACEUTICALS, INC.
KAREN 
 
ROBERTS 
EXECUTIVE OFFICER
ELIXIR PHARMACEUTICALS, INC.   |  CERULEAN PHARMA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-05-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#